secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001641172-25-012536
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals implements 70% salary reduction for all salaried employees, including named executive officers
--------------------------------------------------------------------------------

- Effective May 21, 2025, all salaried employees and named executive officers face a 70% salary reduction.
- Affected executives: Interim CEO Christopher Cooper, COO Peter Dritschilo, CSO Mira Jung, CCO Tyvin Rich, VP Regulatory Michael P. Vander Hoek.
- CFO Timothy Lorber's 70% salary reduction is deferred and will be paid later, unlike the outright reduction for others.
- The salary cuts reflect a significant cost-reduction measure amid apparent financial pressures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225012536/0001641172-25-012536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225012536/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer